Irritable bowel syndrome differential diagnosis: Difference between revisions
Line 311: | Line 311: | ||
on etiology | on etiology | ||
! colspan="1" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Presentation | ! colspan="1" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Presentation | ||
! colspan=" | ! colspan="8" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" | Clinical findings | ||
! colspan="2" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" | Diagnosis | ! colspan="2" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" | Diagnosis | ||
! colspan="1" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" | Comments | ! colspan="1" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" | Comments | ||
Line 323: | Line 323: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Rebound Tenderness | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Rebound Tenderness | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Bowel sounds | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Bowel sounds | ||
! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" | Lab Findings | ! colspan="1" rowspan="1" align="center" style="background:#4479BA; color: #FFFFFF;" | Lab Findings | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Imaging | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Imaging | ||
Line 338: | Line 337: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Ascitic fluid [[PMN]]>250 cells/mm<small>³</small> | * Ascitic fluid [[PMN]]>250 cells/mm<small>³</small> | ||
Line 355: | Line 353: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Ascitic fluid | * Ascitic fluid | ||
Line 374: | Line 371: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 388: | Line 384: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Abnormal [[LFT]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Abnormal [[LFT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation | ||
Line 402: | Line 397: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Hyperbilirubinemia]] | * [[Hyperbilirubinemia]] | ||
Line 418: | Line 412: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[amylase]] / [[lipase]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[amylase]] / [[lipase]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows evidence of [[inflammation]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows evidence of [[inflammation]] | ||
Line 432: | Line 425: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows evidence of [[inflammation]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows evidence of [[inflammation]] | ||
Line 446: | Line 438: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan and ultrasound shows evidence of inflammation | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan and ultrasound shows evidence of inflammation | ||
Line 461: | Line 452: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hyperactive then absent | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hyperactive then absent | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Abdominal X-ray|Abdominal X ray]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Abdominal X-ray|Abdominal X ray]] | ||
Line 469: | Line 459: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 489: | Line 478: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan and [[Abdominal x-ray|abdominal X ray]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan and [[Abdominal x-ray|abdominal X ray]] | ||
Line 503: | Line 491: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[bilirubin]] and [[alkaline phosphatase]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[bilirubin]] and [[alkaline phosphatase]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | ||
Line 517: | Line 504: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hematuria]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hematuria]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan and ultrasound | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan and ultrasound | ||
Line 533: | Line 519: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hyperactive | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hyperactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] and [[lactic acidosis]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] and [[lactic acidosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | ||
Line 547: | Line 532: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>+</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hyperactive then absent | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hyperactive then absent | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | ||
Line 562: | Line 546: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Normal | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Normal | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | ||
Line 576: | Line 559: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Anemia]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Anemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | ||
Line 592: | Line 574: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Pelvic ultrasound]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Pelvic ultrasound]] | ||
Line 607: | Line 588: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[ESR]] and [[CRP]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[ESR]] and [[CRP]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | ||
Line 621: | Line 601: | ||
| +/- | | +/- | ||
|N | |N | ||
|Normal | |Normal | ||
|Laproscopy | |Laproscopy | ||
Line 636: | Line 615: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>+/-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>+/-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[ESR]] and [[CRP]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[ESR]] and [[CRP]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | ||
Line 651: | Line 629: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>-</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |<nowiki>-</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Positive [[pregnancy test]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Positive [[pregnancy test]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | ||
Line 666: | Line 643: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
[[Diagnosis|Clinical diagnosis]] | [[Diagnosis|Clinical diagnosis]] |
Revision as of 23:44, 1 November 2017
Irritable bowel syndrome Microchapters |
Differentiating Irritable bowel syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Irritable bowel syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Irritable bowel syndrome differential diagnosis |
Risk calculators and risk factors for Irritable bowel syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Irritable bowel syndrome must be differentiated from other diseases that cause diarrhea, constipation, and abdominal pain, such as Celiac disease, Inflammatory bowel disease(Crohn's disease and Ulcerative colitis) Thyroid disease (Hyper or Hypothyroidism), strictures due to ischemia, diverticulitis or ischemia, among others.
The differential diagnosis for Irritable bowel syndrome can be listed based on predominant symptoms, such as constipation predominant, diarrhea predominant and pain predominant diseases.
Differentiating Irritable Bowel Syndrome from other Diseases
Diseases with similar symptoms
- Celiac disease
- Crohn's disease
- Zollinger-Ellison syndrome
- VIPoma
- Diverticulitis
- Endometriosis
- Gallstones
- Gastroesophageal reflux disease (GERD)
- Inflammatory bowel disease
- Lactose intolerance
- Thyroid disease- Hyperthyroidism/Hypothyroidism
- Chronic pancreatitis
- Small bacterial overgrowth
- Intermittent small bowel obstruction
Differential Diagnosis of Irritable Bowel Syndrome on the basis of Constipation:
The differential diagnosis of Irritable bowel Syndrome based on constipation is as follows:[1][2][3][4][5][6][7][8][9][10]
Differential Diagnosis for Constipation predominant symptoms | Clinical features | Diagnosis |
---|---|---|
Strictures due to diverticultis,inflammatory bowel disease, ischemia or cancer | ||
Hypothyroidism |
|
|
Medication |
| |
Neurologic disease |
|
|
Pelvic floor dysfunction |
|
|
Colonic inertia |
|
|
Differential Diagnosis of Irritable Bowel Syndrome on the basis of Diarrhea:
The differential diagnosis of Irritable Bowel Syndrome based on diarrhea is as follows:[11][12][13][14][15][16][17][18][19][20]
Differential Diagnosis for Diarrhea predominant symptoms | Clinical features | Diagnosis |
---|---|---|
Crohn's disease |
|
|
Ulcerative colitis |
|
|
Microscopic colitis |
|
|
Celiac disease |
|
|
Neuroendocrine tumor |
| |
Hyperthyroidism |
|
|
Lactose intolerance |
|
|
Infectious causes |
|
|
Small bowel bacterial overgrowth | ||
Clostridium difficile infection(Psuedomembranous colitis) |
|
The diffrentials of chronic watery diarrhea are as follows:
Cause | Osmotic gap | History | Physical exam | Gold standard | Treatment | |||
---|---|---|---|---|---|---|---|---|
< 50 mOsm per kg | > 50 mOsm per kg* | |||||||
Watery | Secretory | Crohns | + | - |
|
|
|
|
Zollinger-Ellison syndrome | + | - |
|
|
|
| ||
Hyperthyroidism | + | - |
|
|||||
VIPoma | + | - |
|
|
| |||
Osmotic | Lactose intolerance | - | + |
|
||||
Celiac disease | - | + |
|
|
|
|||
Functional | Irritable bowel syndrome | - | - | Abdominal pain or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following:
History of straining is also common |
|
Clinical diagnosis
|
|
Template:WikiDoc Sources
Differential diagnosis of abdominal pain
The differential diagnosis based on abdominal pain are as follows:
The following is a list of diseases that present with acute onset severe lower abdominal pain:
References
|